Literature DB >> 24694799

High-normal blood pressure is associated with new-onset electrocardiographic left ventricular hypertrophy.

H Ueda1, M Miyawaki2, H Hiraoka1.   

Abstract

Whether high-normal blood pressure (BP) is a predictor of new-onset electrocardiographic (ECG)-left ventricular hypertrophy (LVH) is not known. A total of 4112 subjects who underwent physical examinations were enrolled in this study. BP was measured on entry. Standard 12-lead ECG was recorded at initial evaluation and 3 years later. BP categories were defined on the basis of the 2013 European Society of Hypertension/European Society of Cardiology guidelines. Of the 4112 subjects, 133 developed ECG-LVH 3 years later. Crude cumulative prevalence rates of new-onset ECG-LVH were 2.0% for the optimal BP group, 3.2% for the normal BP group, 5.1% for the high-normal BP group and 5.0% for the hypertension group. After adjustment for age, gender, body mass index, smoking, low-density lipoprotein cholesterol, log-transformed high-density lipoprotein cholesterol, log-transformed triglycerides, estimated glomerular filtration rate, haemoglobin A1c, haemoglobin, uric acid and antihypertensive medication use, compared with the optimal BP group, the odds ratios of new-onset ECG-LVH for the normal BP, high-normal BP and hypertension groups were 1.52 (95% confidence interval (CI): 0.93-2.49, P=0.094), 2.38 (95% CI: 1.40-4.03, P=0.001) and 2.44 (95% CI: 1.43-4.18, P=0.001), respectively. Even high-normal BP was significantly associated with the presence of new-onset ECG-LVH.

Entities:  

Mesh:

Year:  2014        PMID: 24694799     DOI: 10.1038/jhh.2014.21

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  28 in total

1.  High normal blood pressure is an independent risk factor for cardiovascular disease among middle-aged but not in elderly populations: 9-year results of a population-based study.

Authors:  F Hadaegh; R Mohebi; D Khalili; M Hasheminia; F Sheikholeslami; F Azizi
Journal:  J Hum Hypertens       Date:  2012-01-05       Impact factor: 3.012

2.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

Authors:  W B Kannel; T Gordon; D Offutt
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

3.  Serum uric acid and target organ damage in primary hypertension.

Authors:  Francesca Viazzi; Denise Parodi; Giovanna Leoncini; Angelica Parodi; Valeria Falqui; Elena Ratto; Simone Vettoretti; Gian Paolo Bezante; Massimo Del Sette; Giacomo Deferrari; Roberto Pontremoli
Journal:  Hypertension       Date:  2005-03-21       Impact factor: 10.190

4.  High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey.

Authors:  T Hayashi; K Tsumura; C Suematsu; G Endo; S Fujii; K Okada
Journal:  Diabetes Care       Date:  1999-10       Impact factor: 19.112

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Bjorn Dahlof
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

Review 7.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

Authors:  Daniel Pewsner; Peter Jüni; Matthias Egger; Markus Battaglia; Johan Sundström; Lucas M Bachmann
Journal:  BMJ       Date:  2007-08-28

8.  Five-year findings of the Hypertension Detection and Follow-up Program. Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  Hypertension       Date:  1985 Jan-Feb       Impact factor: 10.190

9.  Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women.

Authors:  David Conen; Usha B Tedrow; Bruce A Koplan; Robert J Glynn; Julie E Buring; Christine M Albert
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  2 in total

1.  Target Organ Damage and Cardiovascular Risk in a Hypertensive Roma Sample Population in Romania.

Authors:  Emma Weiss; Elisabeta Badila; Cristina Japie; Ana Maria Balahura; Daniela Bartos
Journal:  Maedica (Bucur)       Date:  2018-06

2.  Prehypertension is associated with peripheral arterial disease and low ankle-brachial index.

Authors:  Alberto F Rubio-Guerra; Ana K Garro-Almendaro; Jose J Lozano-Nuevo; Karla C Arana-Pazos; Montserrat B Duran-Salgado; Herlinda Morales-López
Journal:  Indian Heart J       Date:  2017-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.